Anticancer Research

Aims & Scope

ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology.

Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed.

ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008).

Each annual volume contains twelve issues and index.

Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).

Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume.

There is no limitation to the number of pages per issue.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.7
2024	1.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.545

Quartile

Year	Value
2024	Q2

Journal Rank

Year	Value
2024	10666

Journal Citation Indicator

Year	Value
2024	3500

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review

  Citation: 262

  Authors: EMMANUEL N., ANTONIOS, ATHANASIOS, DIMITRIOS, AIKATERINI, NIKOLAOS, MICHAIL, KYVELI, GEORGIOS, ATHANASIOS, THOMAS, ZACHARIAS

• Acute Graft Versus Host Disease: A Comprehensive Review

  Citation: 157

  Authors: SAMAH, HIND, EHAB, IMAD

• Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer

  Citation: 157

  Authors: CHRISTOS, SERENA, MICHAEL, ELEFTHERIOS, THEODOROS, EMMANOUIL, ANTONIOS, DEMETRIOS, AFRODITE, SPYRIDON, GERASIMOS, KONSTANTINOS, DESPINA, NIKOLAOS, DIMITRIOS

• Dietary Patterns and Breast Cancer Risk: A Systematic Review

  Citation: 112

  Authors: AKHILA, JESSIE, LAURIE, SARAH

• The Effect of Various Doses of Oral Vitamin D₃Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study

  Citation: 104

  Authors: NIPITH, ARASH, TYLER A., ANJELI, MICHAEL F.

• Ageing as an Important Risk Factor for Cancer

  Citation: 104

  Authors: KAREL, LUKÁŠ, PAVOL, BARBORA, PROKOP, ALEKSI

• Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme

  Citation: 99

  Authors: JIRI, JIRI, LUBOS, TEREZA, VLADIMIR, ONDREJ, KRISTYNA, INKA

• The role of IL-7 in Immunity and Cancer

  Citation: 93

  Authors:

• Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells

  Citation: 93

  Authors: TOSHIHARU, TSUTOMU, ATSUSHI, FUMIHIKO, MITSUTOSHI, RYOSUKE, KOJI, YOSHITAKA, YOUICHI, YOUNG-SOO, YASUSHI, ICHIRO, SHUICHI, KENTARO, YASUHIRO, YOSHIAKI, TOSHIHIKO, HIROYUKI

• Discovery of Anticancer Agents of Diverse Natural Origin

  Citation: 93

  Authors: A. DOUGLAS, ESPERANZA J. CARCACHE, DAVID M, H. LIVA, JIMMY, D. DOEL, NICHOLAS H, CEDRIC J, MANSUKH C, BRENT R, JOANNA E, STEVEN M, JAMES R, MITCHELL A, LIHUI, XIAOLI, YOUNG YONGCHUN

---